Remepy
Digital therapeutics platform enhancing drug efficacy and safety through personalized software.
About
Remepy pioneers Hybrid Drugs, a new class of medicine integrating pharmaceutical molecules with AI-driven digital protocols delivered via app. These Hybrid Drugs measurably improve motor, cognitive, and mental function, with their first product, Hybridopa, targeting Parkinson's Disease. Remepy's approach is regulated like medicine, adaptive like software, and reimbursed like pharma, aiming to deliver superior outcomes. Teams look it up for Healthcare, Drug Development, Biotech.
Frequently asked
What does Remepy do?
Remepy is a Healthcare company that offers Software. Teams look it up for Drug Development, Biotech, Life Sciences. It is based in Tel Aviv, Israel and was founded in 2021. Public records show about 75 people and $15M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Remepy raised?
Remepy has raised a total of $15M in funding. The most recent round on record is Seed.
Where is Remepy headquartered?
Remepy is headquartered in Tel Aviv, Israel.
When was Remepy founded?
Remepy was founded in 2021.
What industry does Remepy operate in?
Remepy operates in Healthcare, Drug Development, Biotech, Life Sciences, HealthTech.
How many employees does Remepy have?
Remepy has approximately 75 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.